Federal Court Says J&J Not Infringing on Boston’s DES Patent
April 9, 2007 — The drug used in Johnson & Johnson’s drug-eluting stent — produced by J&J-owned Cordis — does not infringe on a patent held by Boston Scientific. So rule a U.S. federal judge last week.
U.S. District Court Judge Sue Robinson, Delaware, granted a motion by J&J unit Cordis for summary judgment, saying, "based on the evidence of record, no reasonable juror could find for Boston Scientific on the issue of infringement."
Patent disputes in lower courts had previously ruled in Boston Scientific’s favor.
More like this
- Courts Decide on Boston Scientific, Johnson & Johnson Stent Patent Disputes
- Stent Makers Settle Three Patent Disputes for $1.7 Billion
- Jury Says Cordis Owes $19.5 Million to Boston Scientific
- Court Rules in Favor of Boston Scientific in Stent Lawsuit
- Appellate Court Rules in Favor of Boston Scientific in Stent Patent Case